Back to search

Article

Impact of body mass index on the clinical outcomes of immune checkpoint inhibitor combination therapy for advanced renal cell carcinoma: insights from gene expression and tumor-infiltrating immune cell profile

2026-07-07

Abstract excerpt

<title>Abstract</title> <p> Objective To clarify the prognostic impact of body mass index (BMI) on outcomes with immune checkpoint inhibitor (ICI) combination therapy among patients with advanced renal cell carcinoma (RCC). Methods We retrospectively evaluated clinical data from 229 patients with advanced clear-cell RCC (ccRCC) treated with first-line ICI combination therapy. Patients were stratified by BMI as...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
00911f2b-a40d-50f0-a326-e868c2d710e3
DOI
10.21203/rs.3.rs-9890602/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impact of body mass index on the clinical outcomes of immune checkpoint inhibitor combination therapy for advanced renal cell carcinoma: insights from gene expression and tumor-infiltrating immune cell profileDOI 10.21203/rs.3.rs-9890602/v1
Body mass index-associated molecular characteristics involved in tumor immune and metabolic pathwaysSemantic proximity
Exploring the impact of body mass index on tumor biology and cancer developmentSemantic proximity
An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma.Semantic proximity
Single-cell transcriptome analysis reveals immunosuppressive landscape in overweight and obese colorectal cancerSemantic proximity
Consensus molecular subtype differences linking colon adenocarcinoma and obesity revealed by a cohort transcriptomic analysisSemantic proximity
Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase InhibitorsSemantic proximity
Association between visceral adiposity and DDX11 as a predictor of aggressiveness of small clear-cell renal-cell carcinoma: a prospective clinical trialSemantic proximity
High Body Mass Index Was Related to Favorable Therapeutic Efficacy of Epidermal Growth Factor Receptor Targeted Therapy in Advanced Non-Small Cell Lung CancerSemantic proximity
Association of BMI With Benefit of Metformin Plus Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients With Advanced Lung Adenocarcinoma: A Secondary Analysis of a Phase 2 Randomized Clinical Trial.Semantic proximity
Body mass index-based inflammation index is a promising prognostic predictor in older adult cancer patientsSemantic proximity
The association of body composition phenotypes before chemotherapy with epithelial ovarian cancer mortality.Semantic proximity
Sex-specific Body Composition Features Impacting Survival Outcomes in Surgically Managed Clear Cell Renal Cell CarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.